{"id":59779,"date":"2024-07-31T01:04:49","date_gmt":"2024-07-30T23:04:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/"},"modified":"2024-07-31T01:04:49","modified_gmt":"2024-07-30T23:04:49","slug":"first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/","title":{"rendered":"First Surgery with OssiGraft Prime Highlights its Exceptional Utility"},"content":{"rendered":"
\n

SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, a bioengineering company that entered the orthobiologics field in 2023, announced the first surgery using its next-generation viable bone matrix, OssiGraft Prime\u2122. The launch of this innovative product represents a significant leap forward in orthopedic biologics, offering surgeons and patients meaningful advantages compared to traditional options.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nOssiGraft Prime builds upon the success of Ossium\u2019s established OssiGraft\u2122 viable bone matrix. Like the original OssiGraft product, OssiGraft Prime boasts an unmatched safety profile that leverages Ossium\u2019s industry-leading donor screening, processing, and decontamination protocols, minimizing the risk of infection and disease transmission. OssiGraft donors are far younger than other bone allografts, with a median age of 35 and maximum age of 55. Due to its vertebral bone source, OssiGraft also contains a uniquely high composition of cancellous bone, which promotes faster bone regeneration compared to legacy bone allografts that are rich in cortical bone.<\/p>\n

\nThis next-generation product incorporates innovative processing advancements, resulting in a more cohesive product with a gum-like consistency precisely engineered to meet the demands of orthopedic and spine surgeons. By upgrading to OssiGraft Prime, surgeons can experience optimized handling properties unlike any other viable bone matrix on the market, enabling them to precisely sculpt and apply the graft in the intended location with unprecedented precision and efficiency. The product reliably stays in place and maintains its integrity during post-surgical irrigation.<\/p>\n

\n\u201cOssiGraft Prime is by far the best product on the market. I actually said \u2018wow!\u2019 out loud in the OR when I handled it in surgery for the first time,\u201d said Dr. Jason Piraino, a leader and educator in foot and ankle surgery. \u201cThis product exceeded my expectations. It’s moldable and stays exactly where you want it, which makes it ideal for minimally invasive surgery.\u201d<\/p>\n

\nThe first surgery with OssiGraft Prime, an arthroscopic ankle fusion, required the graft to be precisely shaped and placed through a narrow incision, demonstrating the product\u2019s unique value. Surgeons working with OssiGraft Prime benefit from its ability to consistently fill odd-shaped gaps and tight spaces, allowing them to push the boundaries of possibility in orthopedic procedures.<\/p>\n

\n\u201cThe successful first surgery using OssiGraft Prime is a testament to our unwavering commitment to building a healthier future,\u201d said Kevin Caldwell, CEO, Co-Founder & President of Ossium Health. \u201cWith OssiGraft Prime, we bridged our innovative product development and tightly controlled manufacturing processes from cell therapies to orthopedic biologics, drawing on our unique expertise to deliver a product that represents a new standard of excellence in the OR. We\u2019re extremely proud of OssiGraft Prime and its potential to drive improvements in bone healing and overall patient outcomes.\u201d<\/p>\n

\nOssiGraft Prime is now available nationwide to orthopedic surgeons that are ready to upgrade their tools and unleash new possibilities in their practice.<\/p>\n

\nAbout Ossium Health<\/b><\/p>\n

\nOssium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood and immune diseases. Founded in 2016, the company is led by Kevin Caldwell, CEO, Co-Founder & President, and Erik Woods, Chief Science Officer, Co-Founder & EVP. Ossium Health\u2019s manufacturing facility is registered with the FDA and its laboratory is certified under the Clinical Laboratory Improvement Amendment (CLIA).<\/p>\n

Contacts<\/b> <\/p>\n

\nSales<\/b>
Jacob Carstensen
\n
Ossium Health, Inc.
\n
415-513-5535
\n
products@ossiumhealth.com<\/a><\/p>\n

\nPress<\/b>
Jane Griffin
\n
Ossium Health, Inc.
\n
415-513-5535
\n
press@ossiumhealth.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, a bioengineering company that entered the orthobiologics field in 2023, announced the first surgery using its next-generation viable bone matrix, OssiGraft Prime\u2122. The launch of this innovative product represents a significant leap forward in orthopedic biologics, offering surgeons and patients meaningful advantages compared to traditional options. OssiGraft Prime builds upon the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59779","6":"format-standard","7":"category-industry"},"yoast_head":"\nFirst Surgery with OssiGraft Prime Highlights its Exceptional Utility - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First Surgery with OssiGraft Prime Highlights its Exceptional Utility - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, a bioengineering company that entered the orthobiologics field in 2023, announced the first surgery using its next-generation viable bone matrix, OssiGraft Prime\u2122. The launch of this innovative product represents a significant leap forward in orthopedic biologics, offering surgeons and patients meaningful advantages compared to traditional options. OssiGraft Prime builds upon the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-30T23:04:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240730242333\/en\/2201278\/5\/OssiGraft_Prime_Video.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"First Surgery with OssiGraft Prime Highlights its Exceptional Utility\",\"datePublished\":\"2024-07-30T23:04:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/\"},\"wordCount\":567,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240730242333\\\/en\\\/2201278\\\/5\\\/OssiGraft_Prime_Video.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/\",\"name\":\"First Surgery with OssiGraft Prime Highlights its Exceptional Utility - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240730242333\\\/en\\\/2201278\\\/5\\\/OssiGraft_Prime_Video.jpg\",\"datePublished\":\"2024-07-30T23:04:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240730242333\\\/en\\\/2201278\\\/5\\\/OssiGraft_Prime_Video.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240730242333\\\/en\\\/2201278\\\/5\\\/OssiGraft_Prime_Video.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First Surgery with OssiGraft Prime Highlights its Exceptional Utility\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First Surgery with OssiGraft Prime Highlights its Exceptional Utility - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/","og_locale":"en_US","og_type":"article","og_title":"First Surgery with OssiGraft Prime Highlights its Exceptional Utility - Pharma Trend","og_description":"SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, a bioengineering company that entered the orthobiologics field in 2023, announced the first surgery using its next-generation viable bone matrix, OssiGraft Prime\u2122. The launch of this innovative product represents a significant leap forward in orthopedic biologics, offering surgeons and patients meaningful advantages compared to traditional options. OssiGraft Prime builds upon the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/","og_site_name":"Pharma Trend","article_published_time":"2024-07-30T23:04:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240730242333\/en\/2201278\/5\/OssiGraft_Prime_Video.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"First Surgery with OssiGraft Prime Highlights its Exceptional Utility","datePublished":"2024-07-30T23:04:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/"},"wordCount":567,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240730242333\/en\/2201278\/5\/OssiGraft_Prime_Video.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/","url":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/","name":"First Surgery with OssiGraft Prime Highlights its Exceptional Utility - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240730242333\/en\/2201278\/5\/OssiGraft_Prime_Video.jpg","datePublished":"2024-07-30T23:04:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240730242333\/en\/2201278\/5\/OssiGraft_Prime_Video.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240730242333\/en\/2201278\/5\/OssiGraft_Prime_Video.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/first-surgery-with-ossigraft-prime-highlights-its-exceptional-utility\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"First Surgery with OssiGraft Prime Highlights its Exceptional Utility"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59779"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59779\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}